MK-5046 T2126
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
MK-5046 is a novel BRS-3 agonist, binding to BRS-3 with high affinity (mouse Ki = 1.6 nM, human Ki = 25 nM).
CAS nr:
1022152-70-0
Purity:
98%
Molecular Weight:
444,37
SMILES:
OC(Cc1ncc(CC2(CC2)C(F)(F)F)[nH]1)(c1ccc(cc1)n1cccn1)C(F)(F)F
Formula:
C20H18F6N4O
Pathway:
GPCR/G Protein
Target:
Bombesin Receptor
